Brind.

Kadant, Prudential Financial, Bristol-Myers Squibb, and MMM were noted on July 2, 2025, as high-growth/large-cap stocks under market scrutiny.

1 report, 0 independent Updated Jul 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Prudential plc Kadant Bristol-Myers Squibb MMM

Keep exploring

The entities involved

Prudential plc
British multinational life insurance and financial services company
- Prudential expands its partnership with SoFi, while Benchmark upgrades SoFi's stock rating to Strong Buy.Fri 21:23
Kadant
US-based paper company

Nothing else this week.
Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology (ESMO) Congress in Madrid.Sun 09:20
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.Sat 18:36
MMM
Russian company that perpetrated one of the world's largest Ponzi schemes of all time
- Jefferies Financial Group boosted its price objective for MMM, with MarketBeat aggregating the consensus data.Sat 07:23

Related events

Coverage

Newest first; wire copies grouped

Jul 2Unknown outlet